Skip to content
Agentic OS
Menu

Intelligence / Services / Auditor Changes / Vivos Therapeutics, Inc.

Auditauditor resigned (SEC 8-K)1 Oct 2026

Vivos Therapeutics, Inc.

1 Oct 2026: Auditor resigned (SEC 8-K) · Baker Tilly US, LLP → Baker Tilly. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
1 Oct 2026
Ticker
VVOS
Sector
Medical devices
Sic
3841
Items
4.01, 9.01
Location
Littleton, CO
State
Colorado
Country
United States
SEC CIK
1716166
Reference
0001493152-26-045193
Former
Baker Tilly US, LLP
Engaged
Baker Tilly
Event
Auditor resigned or declined to stand
What this signal means

A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.

  1. Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
  2. 22 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Vivos Therapeutics, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.

Start free

Across AOS Research

Other records for Vivos Therapeutics, Inc. in our registers.

More in Auditor resigned or declined to stand

Auditor Changes

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.